Please assess the completion status of the following clinical trial:

Trial Title: A Pilot Study To Assess Guidance in and Subsequent Use of Mind-Body Techniques on the Quality of Life of Cancer Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* TNM staged tumors Stage I to Stage IV,~* Tumors staged according to the Ann Arbor staging classification system (commonly lymphomas)~* Tumors which don't have a clear-cut staging system such as most types of leukemia and blood or bone marrow cancers~* Tumors staged by the International Federation of Gynecology and Obstetrics (cervix, uterus, ovary, vagina, and vulva).~* No neurological illness~Exclusion Criteria:~* Mental functioning clinically estimated to be below the low average range (IQ\< 80). (Impaired cognitive level might impede verbal comprehension).~* Not being able to speak or understand English;~* No access to reliable computer with operational software to participate in online video conferences~* Unavailability of built-in or external web-cam~* Unavailability of reliable high-speed Internet connection~* Unavailability of reliable transportation to and from face-to-face MBM skills group meetings~* Barring unforeseen circumstances, intent to participate in each and every one of the eight MBM Skills Groups session

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Face-to-Face MBM Skills Group (Type: EXPERIMENTAL): None
- Online MBM Skills Group (Type: EXPERIMENTAL): None
- Waitlist Control I (Type: OTHER): This group will be given the option to participate in a face-to-face MBM skills group intervention after conclusion of study.
- Waitlisted Control II (Type: OTHER): This group will be given the option to participate in an Online MBM skills group intervention after conclusion of study.

Based on this trial design, predict the completion outcome and termination type (if applicable).